Policy responses and statements

Name of organisation:

Medicines and Healthcare Products Regulatory Agency (MHRA)

Name of policy document:

Consultation ARM 44 - Request to Reclassify a Product from P to GSL - Galpharm Hayfever Eye Drops

Deadline for response:

8 October 2007

Background: Consultation ARM 44 sought views on the reclassification from P to GSL of Galpharm Hayfever Eye drops containing sodium cromoglycate 2%. Sodium cromoglycate 2% eye drops have been extensively used as a prescription treatment. They have also been widely available as pharmacy medicines since 1993 for the relief and treatment of seasonal and perennial allergic conjunctivitis in adults and children.

Download this consultation response as a .pdf

Copies of this response are available from:

Lesley Lockhart,
Royal College of Physicians of Edinburgh,
9 Queen Street,
Edinburgh,
EH2 1JQ.

Tel: 0131 225 7324 ext 608
Fax: 0131 220 3939

[5 August 2007]